The International Herald Tribune profiles Steven Nissen , the Cleveland Clinic scientist best known for his early warnings about the safety of Vioxx, long before the drug was taken off the market.
Corporate Directors Strike Back
Merck: New drug safer than Vioxx
New Jersey-based Merck & Co. said Wednesday that a preliminary analysis of trial data shows its successor drug to Vioxx didn't increase patients' risk of cardiovascular events when compared with a traditional pain reliever but that more people withdrew from the study because of other problems, such as high blood pressure.
SAN ANTONIO, May 16 (UPI) -- The Texas Fourth Court of Appeals overturned a $7.75 million verdict against Merck & Co. in a lawsuit over the heart risk of the painkiller Vioxx. More...
Contact:
Copyright © 2005 Vioxx Advisor.com All Rights Reserved